2009

1. Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention-Effects on soluble CD40 ligand concentrations

   Atherosclerosis, Vol. 206, Núm. 2, pp. 523-527

2. Role of Myeloperoxidase as Predictor of Systemic Inflammatory Response Syndrome in Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention

   American Journal of Cardiology, Vol. 104, Núm. 5, pp. 634-637